300453.SZ SHZ
Jiangxi Sanxin Medtec Co.,Ltd.
1W: +0.4%
1M: -4.5%
3M: -3.4%
YTD: -4.3%
1Y: +1.0%
3Y: +41.9%
5Y: -14.9%
¥9.05 ($1.35)
+0.02 (+0.22%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$1.6B
+9.3% ▲
5Y CAGR: +11.8%
Gross Profit
$0
-100.0% ▼
Operating Income
$323M
+15.9% ▲
5Y CAGR: +15.8%
Net Income
$262M
+15.4% ▲
5Y CAGR: +17.8%
EPS (Diluted)
$0.51
+15.9% ▲
5Y CAGR: +18.3%
EBITDA
$323M
-12.4% ▼
5Y CAGR: +9.4%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $1.2B | $1.3B | $1.3B | $1.5B | $1.6B |
| YoY Growth | +23.8% | +14.7% | -2.7% | +15.4% | +9.3% |
| Cost of Revenue | $764M | $887M | $847M | $970M | $0 |
| Gross Profit | $400M | $449M | $453M | $530M | $0 |
| Gross Margin | 34.4% | 33.6% | 34.8% | 35.3% | 0.0% |
| R&D Expenses | $42M | $41M | $51M | $64M | $0 |
| SG&A Expenses | $106M | $108M | $100M | $77M | $0 |
| Operating Expenses | $199M | $223M | $196M | $251M | $1.3B |
| Operating Income | $195M | $230M | $258M | $279M | $323M |
| Operating Margin | 16.8% | 17.2% | 19.8% | 18.6% | 19.7% |
| Interest Expense | $2M | $3M | $5M | $4M | $0 |
| Income Before Tax | $195M | $226M | $253M | $276M | $322M |
| Tax Expense | $24M | $27M | $30M | $28M | $0 |
| Net Income | $156M | $185M | $207M | $227M | $262M |
| Net Margin | 13.4% | 13.8% | 15.9% | 15.2% | 16.0% |
| EPS (Diluted) | $0.30 | $0.36 | $0.40 | $0.44 | $0.51 |
| EBITDA | $259M | $301M | $336M | $370M | $323M |
| Shares Outstanding | 513M | 517M | 519M | 511M | 517M |